DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
S••••• B••••••••• H••••••••• L••
Borrower · H••••••••• & Pharmaceuticals
No date on record · this record
group grade Aon a schedule nowsponsor unattributed
Also written as: LLC Inc. Asset Type
No date on record · this record
What matters now
- 76¢ → 74¢consensus mark
Consensus mark 74¢ on cost, down from 76¢ a year ago, 86¢ last quarter.
Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.
Derived2 of 2 lenders' own marks, weighted by principal - $4.99Mprincipal outstanding
$4.99M principal held by 2 lenders; matures Dec 2029.
Q2 2026 · Refinancing is due in 39 months at a 74¢ mark.
FactBDC schedules of investments, 30 Jun 2026; a sum of the BDCs' pieces, a lower bound - 86¢ → 56¢-30 pts, one lender
A•••••• S•••••••• C••••• F••• marked it 86¢ → 56¢, the largest move among 2 lenders this quarter.
Q2 2026 · One holder repriced far more than the rest.
Mark path, consensus per quarter end
76¢ · 89¢ · 87¢ · 86¢ · 74¢Q2 2025 to Q2 2026
Principal held
at least $5.0M
sum of BDC pieces, a lower bound
Fair value
$3.7M
74c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
6
2 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Dec 31, 2029
no dated debt inside 24 months
On the tape since
Sep 30, 2021
latest Jun 30, 2026
Events
9
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••••• S•••••••• C••••• F••• | $2.99M | 56¢ | -30 pts |
| O••• D••••• L•••••• B•• F••• | $2M | 102¢ | new this quarter |
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••••• S•••••••• C••••• F••• | term loan first lien Asset T••• F•••• L••• T••• L••• R•••••••• R••• and S••••• S + 4.25% I••••••• R••• 8.00% M• | $3.0M | $1.7M 56c | SOFR+425 bp |
| O••• D••••• L•••••• B•• F••• | term loan first lien F•••• L••• T••• L••• R•••••••• R••• and S••••• 3M S••• + 5.75% F•••• 0.75% I••••••• R••• 9 | $2.0M | $2.0M 102c | SOFR+575 bp |
Capital structure as the BDCs see itlatest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $5.0M | 74c | SOFR+575 bp | Dec 31, 2029 | 2 |
| term loan lien unstated exited Sep 30, 2021 | at least $30.2M | 101c | S+500 bp | Oct 1, 2023 | 1 |
| other lien unstated exited Sep 30, 2021 | at least $4,000 | 555c | unstated | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $5.0M | $3.7M | 74c | 0 |
| Mar 31, 2026 | 1 | $3.0M | $2.6M | 86c | 0 |
| Dec 31, 2025 | 1 | $6.0M | $5.2M | 87c | 0 |
| Sep 30, 2025 | 1 | $3.0M | $2.7M | 89c | 0 |
All 15 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1 | $3.0M | $2.3M | 76c | 0 |
| Mar 31, 2025 | 4 | $11.6M | $9.6M | 84c | 0 |
| Dec 31, 2024 | 4 | $11.7M | $9.4M | 82c | 0 |
| Sep 30, 2024 | 4 | $22.8M | $21.2M | 96c | 0 |
| Jun 30, 2024 | 4 | $11.7M | $11.7M | 103c | 0 |
| Mar 31, 2024 | 4 | $11.6M | $11.6M | 102c | 0 |
| Dec 31, 2023 | 3 | $8.4M | $8.4M | 103c | 0 |
| Sep 30, 2023 | 3 | $5.6M | $5.6M | 105c | 0 |
| Jun 30, 2023 | 3 | $5.6M | $5.3M | 105c | 0 |
| Mar 31, 2023 | 2 | $5.4M | $5.2M | 102c | 0 |
| Sep 30, 2021 | 1 | $30.2M | $30.9M | 103c | 0 |
What changed
- Marked down across lendersJun 30, 2026
- Spread changed (observed)Jun 30, 2026
- New lender joined a facilityJun 30, 2026
- Marked down (one lender)Jun 30, 2026
- Mark recoveredSep 30, 2025
Full timeline · 24 eventsShow fewer
- Maturity extended (observed)Sep 30, 2025
- Maturity extended (observed)Sep 30, 2025
- Marked down across lendersJun 30, 2025
- Marked down (one lender)Jun 30, 2025
- Lender left a facilityMar 31, 2025
- Lender left a facilityMar 31, 2025
- Lender left a facilityMar 31, 2025
- Marked down across lendersDec 31, 2024
- Marked down (one lender)Dec 31, 2024
- Marked down (one lender)Dec 31, 2024
- Marked down (one lender)Dec 31, 2024
- Marked down (one lender)Dec 31, 2024
- Marked down (one lender)Sep 30, 2024
- Marked down (one lender)Sep 30, 2024
- Marked down (one lender)Sep 30, 2024
- Marked down (one lender)Sep 30, 2024
- New borrower on a BDC scheduleSep 30, 2021
- Facility left every BDC scheduleSep 30, 2021
- Facility left every BDC scheduleSep 30, 2021
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- S••••• B••••••••• H•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 6 BDCsderived
- Industry
- H••••••••• & Pharmaceuticalsreportedas one filer wrote it
Position history
35 field-level changes across filed schedules, latest first
- Marked downA•••••• S•••••••• C••••• F••• · 86.4% of cost to 55.5% of cost2026-06-30
- New positionO••• D••••• L•••••• B•• F••• · at $2.0M2026-06-30
- Principal decreasedA•••••• S•••••••• C••••• F••• · $6.0M to $3.0M2026-03-31
- Principal increasedA•••••• S•••••••• C••••• F••• · $3.0M to $6.0M2025-12-31
- Maturity extendedA•••••• S•••••••• C••••• F••• · 2028-11-24 to 2029-12-312025-09-30
- Mark recoveredA•••••• S•••••••• C••••• F••• · 76.4% of cost to 89.0% of cost2025-09-30
- Position exitedP••••••••• F••••••• R••• C•••••• L••• · from $3.7M2025-06-30
- Position exitedP••••••••• I••••••••• C••• · from $3.5M2025-06-30
- Marked downA•••••• S•••••••• C••••• F••• · 83.5% of cost to 76.4% of cost2025-06-30
- Position exitedG•••••• S•••• P•••••• C••••• C•••• · from $1.3M2025-06-30
Each line is one position compared between two consecutive BDC schedules of investments: principal, fair value mark, spread, PIK and maturity, as filed with the SEC.